Skip to main content
. 2018 Apr 10;9:43–50. doi: 10.2147/JBM.S129821

Table 1.

Most frequent side effects of all approved TKI

Imatinib Nilotinib Dasatinib Bosutinib Ponatinib
Hematologic Neutropenia Neutropenia, thrombocytopenia
Lab values Phosphate Lipase, ALT, AST, blood glucose Changes in coagulation parameters ALT, AST, Lipase Lipase, blood glucose, cholesterol, triglyceride
Non-lab AEs Muscle cramps, edema Rash, PAOD, other vascular events Pleural effusion, Pulmonal hypertension Nausea, vomiting, diarrhea Rash, PAOD, arterial and venous events, arterial hypertension

Abbreviation: AEs, adverse events; ALT, alanine transaminase; AST, aspartate transaminase; PAOD, peripheral arterial vascular occlusive disease; TKI, tyrosine kinase inhibitors.